<!DOCTYPE html>
<html>
<head>
    <title>BREAKING: Federal Register: Prospective Grant of Exclusive Patent Commercialization License: Streptococcus Pneumonia PSAA Peptide for Treatment of Sepsis and Infection</title>
    <meta charset="UTF-8">
    <style>
        body { font-family: Georgia, serif; max-width: 800px; margin: 0 auto; padding: 20px; }
        h1 { border-bottom: 2px solid #333; }
        .breaking { background: #fff3cd; border-left: 4px solid #dc3545; padding: 15px; }
        .source { background: #f8f9fa; padding: 10px; margin-top: 20px; font-size: 0.9em; }
        .timestamp { color: #666; }
    </style>
</head>
<body>
    <h1>BREAKING: Federal Register: Prospective Grant of Exclusive Patent Commercialization License: Streptococcus Pneumonia PSAA Peptide for Treatment of Sepsis and Infection</h1>
    <p class="timestamp">Published: 2018-06-15 | Source: Federal Register</p>
    <div class="breaking">
        <p><strong>The National Institute of Allergy and Infectious Diseases, an institute of the National Institutes of Health, Department of Health and Human Services, on behalf of the Centers for Disease Control and Prevention, Department of Health and Human Services, is contemplating the grant of an exclusive patent commercialization license to The University of Liverpool, located in Liverpool, UK, to practice the inventions embodied in the patent applications listed in the Supplementary Information section of...</strong></p>
    </div>
    <h2>Document Details</h2>
    <p><strong>Document Type:</strong> Notice</p>
    <p><strong>Agency:</strong> Health and Human Services Department, National Institutes of Health</p>
    <p><strong>Document Number:</strong> 2018-12838</p>
    <p><strong>Publication Date:</strong> 2018-06-15</p>
    <h2>Official Source</h2>
    <p>Read the full document at: <a href="https://www.federalregister.gov/documents/2018/06/15/2018-12838/prospective-grant-of-exclusive-patent-commercialization-license-streptococcus-pneumonia-psaa-peptide">https://www.federalregister.gov/documents/2018/06/15/2018-12838/prospective-grant-of-exclusive-patent-commercialization-license-streptococcus-pneumonia-psaa-peptide</a></p>
    <div class="source"><strong>Source:</strong> Federal Register - 2018-12838</div>
    <p><a href="index.html">Back to Breaking News Wire</a></p>
</body>
</html>
